vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and WESTWOOD HOLDINGS GROUP INC (WHG). Click either name above to swap in a different company.

WESTWOOD HOLDINGS GROUP INC is the larger business by last-quarter revenue ($25.0M vs $19.2M, roughly 1.3× Apyx Medical Corp). WESTWOOD HOLDINGS GROUP INC runs the higher net margin — 3.1% vs -6.8%, a 9.9% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 7.4%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 4.9%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Westwood Studios, Inc. was an American video game developer based in Las Vegas, Nevada. It was founded by Brett Sperry and Louis Castle in 1985 as Brelous Software, but got changed after 2 months into Westwood Associates and was renamed to Westwood Studios when Virgin Games bought the company in 1992. The company was bought by Electronic Arts alongside Virgin Interactive's North American operations in 1998. In January 2003, it was announced that Westwood, alongside Westwood Pacific, would be ...

APYX vs WHG — Head-to-Head

Bigger by revenue
WHG
WHG
1.3× larger
WHG
$25.0M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+27.4% gap
APYX
34.7%
7.4%
WHG
Higher net margin
WHG
WHG
9.9% more per $
WHG
3.1%
-6.8%
APYX
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
4.9%
WHG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
APYX
APYX
WHG
WHG
Revenue
$19.2M
$25.0M
Net Profit
$-1.3M
$782.0K
Gross Margin
62.6%
Operating Margin
0.1%
Net Margin
-6.8%
3.1%
Revenue YoY
34.7%
7.4%
Net Profit YoY
71.9%
EPS (diluted)
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
WHG
WHG
Q1 26
$25.0M
Q4 25
$19.2M
$27.1M
Q3 25
$12.9M
$24.3M
Q2 25
$11.4M
$23.1M
Q1 25
$9.4M
$23.3M
Q4 24
$14.2M
$46.5M
Q3 24
$11.5M
$23.7M
Q2 24
$12.1M
$22.7M
Net Profit
APYX
APYX
WHG
WHG
Q1 26
$782.0K
Q4 25
$-1.3M
$1.8M
Q3 25
$-2.0M
$3.7M
Q2 25
$-3.8M
$1.0M
Q1 25
$-4.2M
$478.0K
Q4 24
$-4.6M
$3.7M
Q3 24
$-4.7M
$-1.2M
Q2 24
$-6.6M
$-378.0K
Gross Margin
APYX
APYX
WHG
WHG
Q1 26
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
Q2 24
61.7%
Operating Margin
APYX
APYX
WHG
WHG
Q1 26
Q4 25
0.1%
8.0%
Q3 25
-6.5%
8.3%
Q2 25
-22.6%
3.8%
Q1 25
-32.4%
-0.3%
Q4 24
-21.4%
10.0%
Q3 24
-31.6%
-2.1%
Q2 24
-45.7%
-18.4%
Net Margin
APYX
APYX
WHG
WHG
Q1 26
3.1%
Q4 25
-6.8%
6.8%
Q3 25
-15.4%
15.4%
Q2 25
-33.2%
4.5%
Q1 25
-44.0%
2.1%
Q4 24
-32.5%
14.5%
Q3 24
-40.9%
-5.0%
Q2 24
-54.0%
-1.7%
EPS (diluted)
APYX
APYX
WHG
WHG
Q1 26
$0.09
Q4 25
$0.21
Q3 25
$0.41
Q2 25
$0.12
Q1 25
$0.05
Q4 24
$0.45
Q3 24
$-0.15
Q2 24
$-0.19
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
WHG
WHG
Cash + ST InvestmentsLiquidity on hand
$31.7M
$23.4M
Total DebtLower is stronger
$37.5M
Stockholders' EquityBook value
$14.5M
$126.1M
Total Assets
$66.8M
$150.4M
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
WHG
WHG
Q1 26
$23.4M
Q4 25
$31.7M
$47.7M
Q3 25
$25.1M
$41.3M
Q2 25
$29.3M
$35.2M
Q1 25
$31.0M
$29.1M
Q4 24
$31.7M
$46.5M
Q3 24
$28.0M
$48.3M
Q2 24
$32.7M
$44.1M
Total Debt
APYX
APYX
WHG
WHG
Q1 26
Q4 25
$37.5M
Q3 25
$37.5M
Q2 25
$37.5M
Q1 25
$37.5M
Q4 24
$37.5M
Q3 24
$37.5M
Q2 24
Stockholders' Equity
APYX
APYX
WHG
WHG
Q1 26
$126.1M
Q4 25
$14.5M
$125.6M
Q3 25
$5.8M
$123.9M
Q2 25
$7.3M
$122.4M
Q1 25
$10.5M
$121.4M
Q4 24
$14.2M
$120.3M
Q3 24
$11.0M
$120.4M
Q2 24
$14.7M
$120.5M
Total Assets
APYX
APYX
WHG
WHG
Q1 26
$150.4M
Q4 25
$66.8M
$162.3M
Q3 25
$57.4M
$154.0M
Q2 25
$58.2M
$146.3M
Q1 25
$60.2M
$135.0M
Q4 24
$64.8M
$150.0M
Q3 24
$60.7M
$151.5M
Q2 24
$65.4M
$147.4M
Debt / Equity
APYX
APYX
WHG
WHG
Q1 26
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
WHG
WHG
Operating Cash FlowLast quarter
$-2.5M
$-2.6M
Free Cash FlowOCF − Capex
$-2.8M
FCF MarginFCF / Revenue
-14.6%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
-3.28×
TTM Free Cash FlowTrailing 4 quarters
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
WHG
WHG
Q1 26
$-2.6M
Q4 25
$-2.5M
$18.9M
Q3 25
$-3.5M
$8.5M
Q2 25
$-1.2M
$7.3M
Q1 25
$-702.0K
$-4.9M
Q4 24
$-2.9M
$21.1M
Q3 24
$-4.4M
$529.0K
Q2 24
$-4.3M
$3.6M
Free Cash Flow
APYX
APYX
WHG
WHG
Q1 26
Q4 25
$-2.8M
$18.8M
Q3 25
$-4.1M
$8.5M
Q2 25
$-1.5M
Q1 25
$-757.0K
$-4.9M
Q4 24
$-3.2M
$21.0M
Q3 24
$-4.6M
$519.0K
Q2 24
$-4.6M
$3.5M
FCF Margin
APYX
APYX
WHG
WHG
Q1 26
Q4 25
-14.6%
69.5%
Q3 25
-31.5%
34.8%
Q2 25
-13.2%
Q1 25
-8.0%
-21.1%
Q4 24
-22.4%
45.2%
Q3 24
-40.0%
2.2%
Q2 24
-38.0%
15.6%
Capex Intensity
APYX
APYX
WHG
WHG
Q1 26
Q4 25
1.4%
0.3%
Q3 25
4.0%
0.3%
Q2 25
2.3%
0.0%
Q1 25
0.6%
0.0%
Q4 24
1.7%
0.2%
Q3 24
1.3%
0.0%
Q2 24
2.4%
0.1%
Cash Conversion
APYX
APYX
WHG
WHG
Q1 26
-3.28×
Q4 25
10.29×
Q3 25
2.29×
Q2 25
7.08×
Q1 25
-10.25×
Q4 24
5.69×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APYX
APYX

Segment breakdown not available.

WHG
WHG

Asset-based$19.3M77%
Trust fees$5.3M21%

Related Comparisons